Healthcare entity
Zydus Lifesciences is most often covered alongside AeroDel, which appears in 1 of these 2 stories. Each story carries 2.5 original sources on average, compared with 3.2 for the broader beat in this window. Their average consequence score of 6.5 runs above the beat's 6.1 for that window.
Last mentioned: Mar 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Zydus Lifesciences is most often covered alongside AeroDel, which appears in 1 of these 2 stories. Each story carries 2.5 original sources on average, compared with 3.2 for the broader beat in this window. Their average consequence score of 6.5 runs above the beat's 6.1 for that window. Coverage clusters in market-trends, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Healthcare stories that mention Zydus Lifesciences, published between March 20, 2026 and March 21, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 43 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Zydus Lifesciences. Shared-story counts are live from our verified record — not editorial picks.
Zydus Lifesciences has launched a Semaglutide injection in India featuring a first-of-its-kind reusable multi-dose pen device. This move aims to improve accessibility and affordability for patients managing Type 2 diabetes and obesity in a high-growth market.
Source: bruneinews.net · biospectrumindia.com
AeroDel has entered into an exclusive licensing agreement with Zydus Lifesciences to launch the Aerolife Mini, a pioneering 'Always Attached' pMDI enhancer. The device is designed to improve medication delivery for respiratory patients by offering a portable, foldable solution that remains permanently fixed to the inhaler.
Source: nepalnational.com · news.webindia123.com
Zydus Lifesciences is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
